Cargando…
Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
In recent years, advances in drug therapy for head and neck squamous cell carcinoma (HNSCC) have progressed rapidly. In addition to cytotoxic anti-cancer agents such as platinum-based drug (cisplatin and carboplatin) and taxane-based drugs (docetaxel and paclitaxel), epidermal growth factor receptor...
Autores principales: | Kitamura, Naoya, Sento, Shinya, Yoshizawa, Yasumasa, Sasabe, Eri, Kudo, Yasusei, Yamamoto, Tetsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795499/ https://www.ncbi.nlm.nih.gov/pubmed/33383632 http://dx.doi.org/10.3390/ijms22010240 |
Ejemplares similares
-
Vertebral fracture and splenomegaly in a head and neck cancer producing granulocyte colony-stimulating factor: A case report of systemic complications associated with a cytokine-producing solid tumor
por: Kitamura, Naoya, et al.
Publicado: (2021) -
Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma
por: Sasabe, Eri, et al.
Publicado: (2017) -
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell‐derived exosome uptake by oral squamous cell carcinoma through macropinocytosis
por: Sasabe, Eri, et al.
Publicado: (2021) -
Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes
por: Sento, Shinya, et al.
Publicado: (2016) -
Detection of Merkel cell polyomavirus in multiple primary oral squamous cell carcinomas
por: Kitamura, Naoya, et al.
Publicado: (2023)